Natalie M Elliott

6PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursMedical virologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 21, 2026
Immunodominant Antiviral T Cell Responses Outcompete Antitumor T Cell Responses to Reduce the Efficacy of Oncolytic Viroimmunotherapy.

|May 12, 2026
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response.

|Apr 09, 2026
Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World Experience.

Oluseyi Abidoye, Angelo Pirozzi, Naohiro Okano

|Apr 01, 2025
Immunodominant antiviral T cell responses outcompete immuno-subdominant antitumor responses to reduce the efficacy of oncolytic viroimmunotherapy.

Richard Vile, Benjamin Kendall, Olivia Liseth

|Sep 02, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers.

Bolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard

|Jun 06, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy.

Pedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin

Pageof 1

Frequent Collaborators

2 joint publications

Mohamad Bassam Sonbol

2 joint publications

Daniel H Ahn

2 joint publications

Tanios S Bekaii-Saab

2 joint publications

Thanich Sangsuwannukul